{"id":"methadone-maintenance-therapy","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Constipation"},{"rate":"30-40","effect":"Sweating"},{"rate":"20-30","effect":"Sedation"},{"rate":"20-30","effect":"Sexual dysfunction"},{"rate":"15-25","effect":"Weight gain"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"QT prolongation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Methadone acts as a full mu opioid receptor agonist with a long half-life (24-36 hours), allowing once-daily dosing. It occupies opioid receptors in the brain, preventing withdrawal symptoms and blocking the euphoric effects of other opioids. This pharmacological action, combined with its sustained duration, makes it effective for maintenance therapy in opioid use disorder by stabilizing patients and reducing illicit drug use.","oneSentence":"Methadone is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to prevent withdrawal symptoms and reduce cravings in opioid-dependent patients.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:34:26.685Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Opioid use disorder maintenance treatment"},{"name":"Chronic pain management"}]},"trialDetails":[{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT04264741","phase":"NA","title":"Transcranial Magnetic Stimulation for Methadone Maintenance Therapy Combined With Methamphetamine Abuse","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2020-02-01","conditions":"Methamphetamine Abuse","enrollment":55},{"nctId":"NCT07314346","phase":"PHASE1","title":"Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone","status":"NOT_YET_RECRUITING","sponsor":"Atea Pharmaceuticals, Inc.","startDate":"2025-12","conditions":"Healthy Volunteer Study","enrollment":32},{"nctId":"NCT05766631","phase":"PHASE3","title":"Treating Polysubstance Use Using a Novel Digital Technology","status":"RECRUITING","sponsor":"Friends Research Institute, Inc.","startDate":"2023-07-26","conditions":"Opioid Use, Opioid Use Disorder, Cocaine Use","enrollment":240},{"nctId":"NCT07251283","phase":"NA","title":"Food Insecurity and Eating Behavior Among Adults Receiving Buprenorphine or Methadone Maintenance Treatment: Pilot Study 2","status":"RECRUITING","sponsor":"University of Vermont","startDate":"2025-11-07","conditions":"Food Security","enrollment":40},{"nctId":"NCT04479475","phase":"NA","title":"Social Networks and Methadone Maintenance Treatment Retention and Antiretroviral Therapy Retention in Tanzania","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2024-03-01","conditions":"Opioid-use Disorder, Adherence, Medication, HIV Infections","enrollment":58},{"nctId":"NCT03282890","phase":"NA","title":"Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs","status":"COMPLETED","sponsor":"University of Connecticut","startDate":"2017-11-20","conditions":"Risk Behavior, HIV/AIDS, Medication Adherence","enrollment":237},{"nctId":"NCT01741311","phase":"NA","title":"Secondary HIV Prevention and Adherence Among HIV-infected Drug Users","status":"COMPLETED","sponsor":"University of Connecticut","startDate":"2012-09","conditions":"Risk Behavior, Medication Adherence, HIV","enrollment":106},{"nctId":"NCT05934591","phase":"NA","title":"Improving Attendance in Community Wise","status":"COMPLETED","sponsor":"University of Illinois at Urbana-Champaign","startDate":"2023-07-06","conditions":"Intervention Engagement and Retention","enrollment":166},{"nctId":"NCT07022782","phase":"NA","title":"MEDiterranean Diet-driven Detoxification of OPioid Addicted patiEnts (MED-DOPE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aristidis Veskoukis","startDate":"2025-03-10","conditions":"Opioid Addiction","enrollment":40},{"nctId":"NCT03987282","phase":"NA","title":"Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia","status":"SUSPENDED","sponsor":"Yale University","startDate":"2022-04-26","conditions":"HIV Seropositivity, Opioid-use Disorder","enrollment":560},{"nctId":"NCT05534815","phase":"NA","title":"Long-Term Treatment of Opioid Use Disorder","status":"RECRUITING","sponsor":"Northern Michigan University","startDate":"2023-03-01","conditions":"Drug Addiction, Employment","enrollment":225},{"nctId":"NCT06288711","phase":"NA","title":"Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD","status":"RECRUITING","sponsor":"University of Vermont","startDate":"2024-06-03","conditions":"Opioid Use Disorder, Posttraumatic Stress Disorder","enrollment":135},{"nctId":"NCT05786599","phase":"PHASE2, PHASE3","title":"Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-03-21","conditions":"Chemotherapy-induced Peripheral Neuropathy","enrollment":50},{"nctId":"NCT05546749","phase":"NA","title":"Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2023-02-08","conditions":"Chronic Pain, Opioid Use Disorder","enrollment":18},{"nctId":"NCT04908410","phase":"","title":"The Norwegian Addiction, Pain and Trauma Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Akershus","startDate":"2021-03-23","conditions":"Chronic Pain, Post-traumatic Stress Disorder, Substance Use Disorders","enrollment":1650},{"nctId":"NCT05161351","phase":"PHASE4","title":"Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2021-07-23","conditions":"Addiction Opiate","enrollment":16},{"nctId":"NCT03843788","phase":"NA","title":"TENS and Opioid Use After Cesarean Delivery","status":"TERMINATED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2018-11-09","conditions":"Cesarean Section Complications, Opioid Use","enrollment":16},{"nctId":"NCT01315054","phase":"NA","title":"A Methadone Maintenance Treatment Outcome Study in Three Provinces in China","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2011-05","conditions":"HIV, Hepatitis C, Syphilis","enrollment":4258},{"nctId":"NCT04254731","phase":"PHASE4","title":"Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oslo University Hospital","startDate":"2015-05-07","conditions":"Adverse Drug Effect, Drug Effect, Heart Arrhythmia","enrollment":10},{"nctId":"NCT05051449","phase":"PHASE1","title":"Ketamine for OUD and Comorbid Depression (OUDCD)","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2022-04-04","conditions":"Opioid Use Disorder, Depressive Disorder","enrollment":5},{"nctId":"NCT02396979","phase":"PHASE4","title":"Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia","status":"COMPLETED","sponsor":"Yale University","startDate":"2010-01","conditions":"Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome, Opiate Addiction","enrollment":300},{"nctId":"NCT05242029","phase":"PHASE2","title":"Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2023-12","conditions":"Opioid Use Disorder","enrollment":""},{"nctId":"NCT05164549","phase":"PHASE3","title":"Extended-release Pharmacotherapy for Opioid Use Disorder","status":"COMPLETED","sponsor":"King's College London","startDate":"2019-08-06","conditions":"Opiate Substitution Treatment","enrollment":342},{"nctId":"NCT03685162","phase":"","title":"Observational Study to Evaluate Levomethadone Safety and Effectiveness in Subjects Under Opioid Maintenance Treatment","status":"COMPLETED","sponsor":"L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.","startDate":"2018-02-27","conditions":"Opioid Addiction","enrollment":103},{"nctId":"NCT01532609","phase":"NA","title":"Methadone Maintenance and HIV Prevention: A Window of Opportunity in China","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2009-03","conditions":"Capacity Building, Drug Use, HIV/AIDS","enrollment":220},{"nctId":"NCT04798534","phase":"NA","title":"Intervention to Facilitate MMT/HIV Service Decentralization in Vietnam","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2020-08-28","conditions":"Opioid-use Disorder","enrollment":120},{"nctId":"NCT02851303","phase":"PHASE4","title":"Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2016-10","conditions":"Neonatal Abstinence Syndrome","enrollment":61},{"nctId":"NCT05861544","phase":"NA","title":"NUTRItion-driven Detoxification of OPioid Addicted patiEnts","status":"UNKNOWN","sponsor":"Organization Against Drugs (ΟΚΑΝΑ)","startDate":"2023-03-23","conditions":"Psychiatry","enrollment":58},{"nctId":"NCT05341219","phase":"NA","title":"Light Needle for Opioid Use Disorder","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-03-18","conditions":"Opioid Use Disorder","enrollment":100},{"nctId":"NCT05678036","phase":"","title":"Effects on Mortality and Clinical Course of a Patient's Choice Model for Opioid Maintenance Treatment for Opioid Dependence - Evaluation of a System Enabling a Large Expansion of Treatment Providers and Treatment Access","status":"UNKNOWN","sponsor":"Region Skane","startDate":"2023-01-31","conditions":"Opioid Dependence, Overdose","enrollment":2500},{"nctId":"NCT03065049","phase":"NA","title":"Transforming Recovery Through Exercise and Community","status":"COMPLETED","sponsor":"Butler Hospital","startDate":"2016-09-30","conditions":"Opioid-use Disorder","enrollment":81},{"nctId":"NCT03729388","phase":"","title":"Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2019-05-28","conditions":"Opioid-use Disorder","enrollment":29},{"nctId":"NCT02487745","phase":"NA","title":"The Long-Term Treatment of Drug Addiction and Unemployment","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2015-11","conditions":"Substance Abuse, Intravenous","enrollment":91},{"nctId":"NCT01936857","phase":"PHASE4","title":"Buprenorphine to Improve HIV Care Engagement and Outcomes","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2015-07","conditions":"HIV, Substance Related Disorders","enrollment":281},{"nctId":"NCT04308694","phase":"EARLY_PHASE1","title":"Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2020-08-06","conditions":"Opioid-use Disorder","enrollment":20},{"nctId":"NCT02991599","phase":"PHASE4","title":"Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients","status":"COMPLETED","sponsor":"Shanxi Medical University","startDate":"2014-10","conditions":"Hepatitis B Vaccine","enrollment":196},{"nctId":"NCT00838981","phase":"PHASE1, PHASE2","title":"Pharmacotherapy & CM for Opioid and Cocaine Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2008-05","conditions":"Cocaine Dependence","enrollment":91},{"nctId":"NCT01999946","phase":"PHASE4","title":"Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2014-06-27","conditions":"Heroin Dependence, Opioid-Related Disorders","enrollment":217},{"nctId":"NCT03016598","phase":"PHASE2","title":"Stimulant Oxytocin Study","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2018-01-26","conditions":"Stimulant Use & Co-occuring Opioid Use Disorders","enrollment":42},{"nctId":"NCT01027754","phase":"PHASE4","title":"Smoking Cessation Treatment for Methadone Maintenance Patients","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2009-08","conditions":"Smoking Cessation, Substance-Related Disorders","enrollment":112},{"nctId":"NCT01378858","phase":"NA","title":"Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2011-07","conditions":"Tobacco Use Disorder, Medication Adherence","enrollment":100},{"nctId":"NCT03575273","phase":"NA","title":"The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-02-12","conditions":"Opioid Dependence, Obesity","enrollment":45},{"nctId":"NCT02468544","phase":"NA","title":"Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2017-03","conditions":"HIV, Adherence","enrollment":""},{"nctId":"NCT03098407","phase":"NA","title":"Opioid Dependence Treatment Therapies in Pregnancy","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2017-04-20","conditions":"Opioid-Related Disorders, Pregnancy","enrollment":55},{"nctId":"NCT03194295","phase":"PHASE2","title":"Activating Community Support for Substance Users","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-01-10","conditions":"Substance Use Disorders","enrollment":49},{"nctId":"NCT01334580","phase":"PHASE1","title":"Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment","status":"COMPLETED","sponsor":"Yale University","startDate":"2011-04","conditions":"Chronic Pain, Opiate Dependence","enrollment":40},{"nctId":"NCT01315184","phase":"PHASE2","title":"Study of Computer-Based Treatment for Drug Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2010-07","conditions":"Opioid-Related Disorders, Heroin Dependence","enrollment":36},{"nctId":"NCT00757744","phase":"PHASE3","title":"Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-09","conditions":"Opiate Dependence, HIV Infections","enrollment":45},{"nctId":"NCT01389180","phase":"PHASE3","title":"Behavioral Drug and HIV Risk Reduction Counseling With MMT in China","status":"COMPLETED","sponsor":"Yale University","startDate":"2010-12","conditions":"Opiate Dependence","enrollment":300},{"nctId":"NCT03952455","phase":"NA","title":"Deep Brain Stimulation of the Bilateral Nucleus Accumbens for Patients With Methadone Maintenance Treatment","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2019-05-13","conditions":"Addiction Opiate","enrollment":12},{"nctId":"NCT00292110","phase":"PHASE1","title":"Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2004-02-01","conditions":"Opiate-Related Disorders, Cocaine-Related Disorders","enrollment":140},{"nctId":"NCT00780702","phase":"PHASE1","title":"Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2008-05-08","conditions":"Cocaine Dependence, Cocaine-Related Disorders, Opioid-Related Disorders","enrollment":41},{"nctId":"NCT00505583","phase":"PHASE1","title":"Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy","status":"WITHDRAWN","sponsor":"Bausch Health Americas, Inc.","startDate":"2007-07","conditions":"Methadone-maintenance Subjects","enrollment":""},{"nctId":"NCT00444158","phase":"PHASE1","title":"Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2007-03","conditions":"Constipation","enrollment":24},{"nctId":"NCT00447811","phase":"PHASE1","title":"Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2007-03","conditions":"Methadone-maintenance Subjects","enrollment":""},{"nctId":"NCT00387491","phase":"PHASE1","title":"Dose Ranging Study in Healthy Methadone Maintenance Subjects","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2006-06","conditions":"Adult","enrollment":16},{"nctId":"NCT00398502","phase":"PHASE1","title":"Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2006-10","conditions":"Metahdone-maintenance Subjects","enrollment":""},{"nctId":"NCT01958476","phase":"PHASE3","title":"Improving Outcomes in Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2013-09","conditions":"Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal","enrollment":117},{"nctId":"NCT02593396","phase":"PHASE2","title":"Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2015-12","conditions":"Sexual Dysfunctions, Psychological, Hypoactive Sexual Desire Disorder, Erectile Dysfunctions","enrollment":80},{"nctId":"NCT02502175","phase":"PHASE3","title":"Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2017-06-22","conditions":"Opioid Dependence","enrollment":204},{"nctId":"NCT02715700","phase":"PHASE1","title":"Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-09-28","conditions":"Human Immunodeficiency Virus (HIV) Infection","enrollment":14},{"nctId":"NCT03962816","phase":"PHASE4","title":"Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients","status":"UNKNOWN","sponsor":"Shanxi Medical University","startDate":"2019-05-26","conditions":"Hepatitis B Vaccine","enrollment":300},{"nctId":"NCT02028533","phase":"PHASE1","title":"Cocaine Opioid Oxytocin Option - Limited","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2014-07","conditions":"Opioid Use Disorder, Cocaine Use Disorder","enrollment":30},{"nctId":"NCT00420771","phase":"PHASE2","title":"Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2007-01","conditions":"Benzodiazepine Dependence, Opioid Dependence","enrollment":19},{"nctId":"NCT00061100","phase":"PHASE1","title":"HIV Counseling Intervention for Methadone-Maintained Patients - 2","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"1999-10","conditions":"Opioid-Related Disorders","enrollment":50},{"nctId":"NCT03882125","phase":"NA","title":"Mindfulness-Based Relapse Prevention for Methadone Maintenance","status":"COMPLETED","sponsor":"Pacific University","startDate":"2015-02-15","conditions":"Substance-Related Disorders","enrollment":14},{"nctId":"NCT03881618","phase":"NA","title":"Efficacy of Electro-Acupuncture Therapy for Patients With Methadone Maintenance Treatment","status":"UNKNOWN","sponsor":"Taipei City Hospital","startDate":"2017-04-21","conditions":"Sleep Disorder (Disorder)","enrollment":40},{"nctId":"NCT00809835","phase":"PHASE2","title":"Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-12","conditions":"Cocaine Dependence","enrollment":120},{"nctId":"NCT01847729","phase":"","title":"OPAL: \"Opiates and PhArmacoLogy\"","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2013-07-11","conditions":"Substance Use Disorder","enrollment":263},{"nctId":"NCT00218036","phase":"PHASE2","title":"Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2006-07","conditions":"Cocaine Abuse, Opiate Dependence","enrollment":54},{"nctId":"NCT03603158","phase":"","title":"KCNH2 Polymorphisms on the QTc Interval in Kelantanese Malays Patients Receiving Methadone Maintenance Therapy (MMT)","status":"COMPLETED","sponsor":"Universiti Sains Malaysia","startDate":"2011-02-01","conditions":"Opioid Dependence, Methadone Toxicity, HERG Gene Mutation","enrollment":111},{"nctId":"NCT01142986","phase":"NA","title":"Evaluating Three Methods for Helping Syringe Exchangers Begin Methadone Maintenance","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2010-07","conditions":"Substance Abuse Disorder","enrollment":223},{"nctId":"NCT00000311","phase":"PHASE3","title":"Combining Behavioral Treatment With Agonist Maintenance - 1","status":"COMPLETED","sponsor":"Yale University","startDate":"1995-02","conditions":"Cocaine-Related Disorders, Opioid-Related Disorders, Substance-Related Disorders","enrollment":168},{"nctId":"NCT00249470","phase":"NA","title":"The Therapeutic Workplace Initiation Study","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2003-04","conditions":"Cocaine-Related Disorders, Opioid-Related Disorders, Heroin Dependence","enrollment":117},{"nctId":"NCT01416584","phase":"NA","title":"A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2008-10","conditions":"Opiate Dependence","enrollment":98},{"nctId":"NCT01561079","phase":"PHASE2, PHASE3","title":"Fetal and Infant Effects of Maternal Buprenorphine Treatment","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-02","conditions":"Neonatal Abstinence Syndrome","enrollment":127},{"nctId":"NCT01632982","phase":"NA","title":"Mobile Psychosocial Interventions for MMT Clients","status":"UNKNOWN","sponsor":"National Development and Research Institutes, Inc.","startDate":"2013-07","conditions":"Opioid Abuse, Substance Abuse","enrollment":219},{"nctId":"NCT01642030","phase":"PHASE1","title":"Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2013-08","conditions":"Opioid Dependence, Pain, Addiction","enrollment":132},{"nctId":"NCT01760720","phase":"NA","title":"Methadone Maintenance Treatment (MMT) Care for HIV Prevention","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2012-03","conditions":"Stigma","enrollment":2866},{"nctId":"NCT01873989","phase":"PHASE1, PHASE2","title":"Testosterone Replacement for Male Opioid Agonist Maintained Patients","status":"COMPLETED","sponsor":"Yale University","startDate":"2012-04","conditions":"Chronic Pain, Opioid Addiction, Symptomatic Hypogonadism","enrollment":15},{"nctId":"NCT01644864","phase":"PHASE4","title":"Can Post-operative TAP Block Improve Quality of Recovery After C-sections in Patients on Methadone Maintenance?","status":"WITHDRAWN","sponsor":"Thomas Jefferson University","startDate":"2012-07","conditions":"Uncontrolled Postoperative Pain","enrollment":""},{"nctId":"NCT01396005","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-09","conditions":"Hepatitis C Virus","enrollment":21},{"nctId":"NCT03071315","phase":"","title":"Economic Evaluation Comparing CCT With MMT in Hai Phong City, Vietnam","status":"COMPLETED","sponsor":"The University of New South Wales","startDate":"2013-01-20","conditions":"Heroin Dependence","enrollment":522},{"nctId":"NCT00000200","phase":"PHASE2","title":"Cocaine Effects in Humans: Physiology and Behavior - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"1997-01","conditions":"Cocaine-Related Disorders","enrollment":19},{"nctId":"NCT00218556","phase":"NA","title":"Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2004-01","conditions":"Depressive Disorder, Major, Hepatitis C","enrollment":42},{"nctId":"NCT00218127","phase":"PHASE2","title":"Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2001-11","conditions":"Heroin Dependence, Opioid-Related Disorders","enrollment":142},{"nctId":"NCT01802515","phase":"NA","title":"A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment","status":"TERMINATED","sponsor":"Yale University","startDate":"2012-12","conditions":"Cocaine Dependence, Opiate Dependence","enrollment":14},{"nctId":"NCT01668706","phase":"","title":"Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid Addicts","status":"COMPLETED","sponsor":"National Health Research Institutes, Taiwan","startDate":"2009-03","conditions":"Heroin Dependence","enrollment":340},{"nctId":"NCT01389544","phase":"PHASE1","title":"A Study on the Interaction Between Danoprevir/Ritonavir and Methadone","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-06","conditions":"Healthy Volunteer","enrollment":18},{"nctId":"NCT01841320","phase":"NA","title":"Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2011-10","conditions":"HIV, Addiction","enrollment":378},{"nctId":"NCT00894452","phase":"","title":"Variance of Oral Methadone Dosage: Description of Implicated Factors","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-12","conditions":"Heroin Dependence","enrollment":210},{"nctId":"NCT00170339","phase":"","title":"Bone Density and Serum Testosterone in Male Methadone Maintained Patients","status":"COMPLETED","sponsor":"Hennepin Healthcare Research Institute","startDate":"2005-04","conditions":"Opiate Dependence, Osteoporosis, Erectile Dysfunction","enrollment":60},{"nctId":"NCT00351026","phase":"PHASE3","title":"Methadone Maintenance & HIV Risk in Ukraine","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2008-06","conditions":"Opioid Dependence","enrollment":50},{"nctId":"NCT01693978","phase":"NA","title":"Contingency Outcomes in Prolonged Exposure","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-09","conditions":"Posttraumatic Stress Disorder, Substance Use Disorder","enrollment":126},{"nctId":"NCT01131273","phase":"PHASE3","title":"HIV Risk Reduction in Subutex Injectors in Tbilisi","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-06","conditions":"HIV","enrollment":68},{"nctId":"NCT01360463","phase":"PHASE2","title":"Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-05","conditions":"HIV Risk Behaviors, Heroin Injection, Retention in Methadone Treatment","enrollment":276},{"nctId":"NCT02062736","phase":"","title":"Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.","status":"COMPLETED","sponsor":"L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.","startDate":"2010-02","conditions":"Heroin Addiction","enrollment":500},{"nctId":"NCT00087594","phase":"PHASE4","title":"A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2003-11","conditions":"Hepatitis C, Chronic","enrollment":48},{"nctId":"NCT02698098","phase":"","title":"Comparative Evaluation of PUSPENs and C&Cs","status":"TERMINATED","sponsor":"University of Malaya","startDate":"2012-08","conditions":"Opioid-Related Disorders","enrollment":281}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":635,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Methadone Maintenance Therapy","genericName":"Methadone Maintenance Therapy","companyName":"Oregon Health and Science University","companyId":"oregon-health-and-science-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methadone is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to prevent withdrawal symptoms and reduce cravings in opioid-dependent patients. Used for Opioid use disorder maintenance treatment, Opioid dependence, Chronic pain management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}